First Header Logo Second Header Logo

Edward Levine

Concepts (567)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peritoneal Neoplasms
98
2020
259
21.420
Why?
Hyperthermia, Induced
86
2020
243
16.020
Why?
Chemotherapy, Cancer, Regional Perfusion
56
2020
155
10.720
Why?
Appendiceal Neoplasms
32
2020
98
9.840
Why?
Adenocarcinoma
48
2019
308
6.950
Why?
Antineoplastic Combined Chemotherapy Protocols
49
2020
458
6.890
Why?
Combined Modality Therapy
85
2020
560
5.030
Why?
Breast Neoplasms
45
2021
765
4.900
Why?
Stomach Neoplasms
29
2019
84
4.820
Why?
Antineoplastic Agents
31
2020
608
4.820
Why?
Sentinel Lymph Node Biopsy
24
2020
70
4.280
Why?
Survival Rate
81
2020
877
3.950
Why?
Colorectal Neoplasms
22
2020
215
3.880
Why?
Neoplasm Staging
69
2021
447
3.680
Why?
Middle Aged
189
2021
11817
3.570
Why?
Neoplasm Recurrence, Local
32
2020
367
3.540
Why?
Mitomycin
21
2020
51
3.250
Why?
Humans
267
2021
32005
3.240
Why?
Carcinoma
16
2016
91
3.240
Why?
Female
210
2021
19959
3.140
Why?
Melanoma
14
2019
164
3.070
Why?
Adult
139
2021
9345
3.060
Why?
Aged
144
2021
10301
2.960
Why?
Prognosis
71
2020
1497
2.820
Why?
Adenocarcinoma, Mucinous
6
2020
29
2.790
Why?
Retrospective Studies
98
2020
3509
2.700
Why?
Quality of Life
15
2020
946
2.700
Why?
Male
163
2020
19165
2.640
Why?
Postoperative Complications
26
2018
780
2.540
Why?
Skin Neoplasms
11
2019
214
2.370
Why?
Follow-Up Studies
66
2021
2265
2.330
Why?
Treatment Outcome
68
2021
3306
2.330
Why?
Adrenocortical Carcinoma
16
2019
35
2.210
Why?
Adrenal Cortex Neoplasms
16
2019
36
2.210
Why?
Aged, 80 and over
71
2021
3990
2.180
Why?
Lymph Nodes
14
2019
107
2.150
Why?
Colonic Neoplasms
9
2016
71
2.050
Why?
Chemotherapy, Adjuvant
31
2019
190
2.030
Why?
Prospective Studies
44
2021
2282
1.950
Why?
Mesothelioma
10
2019
39
1.950
Why?
Gastrectomy
22
2018
68
1.920
Why?
Liver Neoplasms
12
2018
155
1.740
Why?
Peritoneum
8
2020
33
1.730
Why?
Neoplasms
14
2020
726
1.720
Why?
Mastectomy
14
2020
64
1.720
Why?
Esophageal Neoplasms
6
2014
35
1.700
Why?
Infusions, Parenteral
22
2016
65
1.670
Why?
Lymphatic Metastasis
29
2020
166
1.590
Why?
Lymph Node Excision
18
2019
89
1.540
Why?
Radiography, Thoracic
2
2019
45
1.290
Why?
Radiopharmaceuticals
9
2010
93
1.290
Why?
Pseudomyxoma Peritonei
7
2014
12
1.280
Why?
Young Adult
31
2020
2636
1.260
Why?
Mammaplasty
6
2013
26
1.080
Why?
Antibiotics, Antineoplastic
8
2011
74
1.050
Why?
Fluorodeoxyglucose F18
7
2010
50
1.050
Why?
Survival Analysis
30
2017
483
1.030
Why?
Sarcoma
6
2020
73
0.960
Why?
Organoplatinum Compounds
5
2013
46
0.950
Why?
Rectal Neoplasms
4
2013
18
0.950
Why?
Jejunal Neoplasms
3
2013
7
0.950
Why?
Adrenalectomy
8
2018
30
0.910
Why?
Disease-Free Survival
22
2018
317
0.860
Why?
Positron-Emission Tomography
6
2010
163
0.860
Why?
Mastectomy, Segmental
7
2021
27
0.830
Why?
Predictive Value of Tests
14
2019
876
0.830
Why?
Duodenal Neoplasms
2
2013
5
0.830
Why?
Blood Cell Count
2
2019
29
0.800
Why?
Morbidity
10
2017
98
0.790
Why?
Mutation
6
2017
489
0.770
Why?
Neoadjuvant Therapy
6
2019
67
0.760
Why?
Carcinoma, Lobular
4
2015
12
0.760
Why?
Neoplasm Invasiveness
12
2017
190
0.730
Why?
Surgical Wound Infection
3
2019
84
0.720
Why?
Abdominal Neoplasms
3
2014
14
0.720
Why?
Negative-Pressure Wound Therapy
2
2019
35
0.710
Why?
Ileal Neoplasms
2
2013
4
0.710
Why?
Ovarian Neoplasms
5
2016
96
0.700
Why?
Depression
4
2020
444
0.700
Why?
Pancreatectomy
5
2019
27
0.690
Why?
Gynecology
1
2019
17
0.680
Why?
Hepatectomy
7
2018
56
0.670
Why?
Gene Expression Profiling
4
2020
322
0.670
Why?
Obstetrics
1
2019
26
0.660
Why?
Workplace
1
2019
49
0.660
Why?
Proportional Hazards Models
14
2020
753
0.660
Why?
Liver Function Tests
1
2019
22
0.660
Why?
Esophagectomy
4
2014
15
0.640
Why?
Severity of Illness Index
4
2018
881
0.640
Why?
Carcinoma, Merkel Cell
2
2009
9
0.640
Why?
Pancreatic Neoplasms
6
2019
134
0.640
Why?
Burnout, Professional
1
2019
51
0.640
Why?
Adolescent
21
2018
3539
0.620
Why?
Carcinoma, Intraductal, Noninfiltrating
5
2020
21
0.620
Why?
Caregivers
1
2020
114
0.620
Why?
Rosaniline Dyes
6
2009
18
0.620
Why?
United States
32
2019
3939
0.610
Why?
Carcinoma, Ductal, Breast
5
2020
30
0.610
Why?
Enteral Nutrition
2
2015
30
0.600
Why?
Neoplasms, Glandular and Epithelial
3
2016
11
0.590
Why?
Retroperitoneal Neoplasms
3
2019
18
0.580
Why?
Digestive System Neoplasms
1
2017
3
0.570
Why?
Laparotomy
1
2017
29
0.570
Why?
Coloring Agents
4
2009
29
0.560
Why?
Cohort Studies
14
2018
1817
0.550
Why?
Sensitivity and Specificity
13
2018
582
0.550
Why?
Carboplatin
4
2013
48
0.540
Why?
Length of Stay
8
2019
314
0.520
Why?
Leiomyosarcoma
3
2010
9
0.490
Why?
Intraoperative Care
7
2015
48
0.480
Why?
Genetic Testing
2
2013
96
0.480
Why?
Angiogenesis Inhibitors
1
2014
36
0.480
Why?
Thalidomide
1
2014
31
0.470
Why?
Radiotherapy, Adjuvant
13
2019
78
0.470
Why?
Registries
9
2018
298
0.470
Why?
Cytological Techniques
2
2011
17
0.460
Why?
Multivariate Analysis
10
2016
684
0.460
Why?
Urinary Bladder Neoplasms
2
2017
192
0.440
Why?
Adjuvants, Immunologic
2
2011
55
0.440
Why?
Nipples
1
2013
3
0.440
Why?
Breast Diseases
1
2013
4
0.440
Why?
Databases, Factual
11
2018
355
0.430
Why?
Gene Expression Regulation, Neoplastic
3
2009
261
0.420
Why?
Pancreaticoduodenectomy
2
2019
20
0.420
Why?
Health Status
5
2019
399
0.420
Why?
Intraoperative Period
6
2011
42
0.410
Why?
BCG Vaccine
1
2011
8
0.400
Why?
Mastectomy, Modified Radical
1
2011
2
0.400
Why?
Genes, BRCA2
2
2011
8
0.390
Why?
Biopsy, Needle
4
2005
93
0.390
Why?
Breast
2
2020
68
0.390
Why?
Cisplatin
6
2014
76
0.390
Why?
Adenomatous Polyposis Coli
1
2011
5
0.380
Why?
Secondary Prevention
1
2011
63
0.380
Why?
Lung Neoplasms
5
2017
412
0.380
Why?
Societies, Medical
2
2016
163
0.380
Why?
Adenoma
1
2011
35
0.370
Why?
Histocytological Preparation Techniques
1
2010
2
0.370
Why?
Biopsy
3
2020
259
0.360
Why?
Medical Oncology
1
2011
86
0.360
Why?
Thoracoscopy
1
2010
9
0.360
Why?
Incidence
9
2019
1199
0.360
Why?
Technetium Tc 99m Sulfur Colloid
2
2009
5
0.360
Why?
Organoids
3
2020
94
0.350
Why?
Colectomy
3
2014
24
0.350
Why?
Nutrition Assessment
2
2014
55
0.340
Why?
Mammography
4
2005
41
0.340
Why?
Tomography, Emission-Computed
3
2005
23
0.340
Why?
Subcutaneous Tissue
1
2009
6
0.330
Why?
Neoplasms, Connective Tissue
1
2009
2
0.330
Why?
Diagnostic Tests, Routine
2
2019
24
0.330
Why?
Drug Screening Assays, Antitumor
2
2019
58
0.330
Why?
Uterine Neoplasms
1
2009
27
0.330
Why?
Disease Progression
7
2017
594
0.320
Why?
Neuroendocrine Tumors
2
2019
18
0.320
Why?
Disease Management
2
2020
126
0.320
Why?
Yoga
1
2009
50
0.310
Why?
Pregnancy Complications, Neoplastic
2
2011
4
0.310
Why?
Pleural Neoplasms
2
2007
11
0.310
Why?
Catheter Ablation
3
2004
67
0.300
Why?
Risk Factors
13
2017
3876
0.300
Why?
Frozen Sections
4
2014
18
0.300
Why?
Fertility Agents, Female
1
2007
8
0.300
Why?
Leuprolide
1
2007
7
0.300
Why?
Breast Neoplasms, Male
1
2007
11
0.290
Why?
Microwaves
1
2007
8
0.290
Why?
Biopsy, Fine-Needle
3
2007
53
0.290
Why?
Electrocoagulation
1
2007
12
0.290
Why?
Neoplasm Metastasis
9
2019
220
0.290
Why?
Polymorphism, Genetic
4
2011
184
0.290
Why?
Deoxycytidine
5
2013
68
0.290
Why?
Mental Health
2
2019
117
0.280
Why?
Models, Biological
2
2019
392
0.280
Why?
Pilot Projects
7
2019
545
0.280
Why?
Carcinoma, Squamous Cell
4
2012
154
0.280
Why?
Logistic Models
7
2018
781
0.280
Why?
Focal Nodular Hyperplasia
1
2006
3
0.280
Why?
Hemoperitoneum
1
2006
4
0.270
Why?
Patient Readmission
3
2016
126
0.270
Why?
Activities of Daily Living
4
2011
257
0.270
Why?
Blood Transfusion
2
2017
73
0.270
Why?
Feasibility Studies
6
2019
293
0.260
Why?
Child
7
2014
2438
0.260
Why?
Head and Neck Neoplasms
1
2007
130
0.260
Why?
Reproducibility of Results
6
2020
762
0.260
Why?
DNA Repair
4
2014
64
0.260
Why?
Nomograms
2
2016
32
0.260
Why?
Obesity
1
2013
1175
0.260
Why?
European Continental Ancestry Group
4
2017
1166
0.250
Why?
Jejunostomy
2
2015
8
0.250
Why?
Preoperative Care
3
2013
114
0.250
Why?
Receptor, erbB-2
2
2014
65
0.250
Why?
North Carolina
8
2015
1514
0.250
Why?
Gallbladder Neoplasms
2
2015
34
0.250
Why?
Intussusception
1
2004
2
0.240
Why?
Liposarcoma, Myxoid
1
2004
2
0.240
Why?
Reoperation
5
2017
226
0.240
Why?
Colonoscopy
2
2019
45
0.240
Why?
Genetic Markers
2
2015
124
0.230
Why?
Genes, erbB-2
1
2003
6
0.230
Why?
Cluster Analysis
2
2015
125
0.230
Why?
Blood Platelets
2
2015
39
0.230
Why?
Parathyroid Neoplasms
1
2003
7
0.230
Why?
Vascular Surgical Procedures
3
2015
88
0.220
Why?
Ethnic Groups
3
2016
476
0.220
Why?
Age Factors
8
2017
1188
0.220
Why?
Prostatic Neoplasms
2
2013
471
0.220
Why?
Camptothecin
2
2005
51
0.220
Why?
Neutrophils
2
2015
106
0.220
Why?
Time Factors
8
2020
2149
0.220
Why?
Surgical Flaps
3
2013
72
0.210
Why?
Patient Selection
4
2020
276
0.210
Why?
Interferon-alpha
1
2003
70
0.210
Why?
Genes, p53
3
2017
23
0.210
Why?
Cytodiagnosis
3
2011
15
0.210
Why?
DNA, Neoplasm
2
2017
55
0.210
Why?
Pregnancy
3
2019
997
0.210
Why?
Clinical Trials as Topic
3
2009
301
0.210
Why?
Injections, Intraperitoneal
5
2014
45
0.200
Why?
Lymphocytes
2
2015
57
0.200
Why?
Health Services Accessibility
3
2019
241
0.200
Why?
Diagnosis, Differential
6
2020
517
0.190
Why?
Hospital Mortality
3
2017
198
0.190
Why?
Consensus
2
2013
85
0.190
Why?
Unnecessary Procedures
1
2020
16
0.180
Why?
GTP Phosphohydrolases
1
2020
9
0.180
Why?
Anus Neoplasms
2
2012
13
0.180
Why?
Extremities
1
2020
50
0.180
Why?
Pelvis
2
2018
61
0.180
Why?
Proto-Oncogene Proteins p21(ras)
1
2020
14
0.180
Why?
Precancerous Conditions
1
2020
27
0.180
Why?
Health Care Rationing
1
2020
12
0.180
Why?
Necrosis
2
2013
53
0.180
Why?
Quality Assurance, Health Care
1
2020
72
0.180
Why?
Immune System Phenomena
1
2020
5
0.180
Why?
Oncogenes
1
2020
13
0.180
Why?
Radiotherapy Dosage
4
2010
101
0.170
Why?
Remote Consultation
1
2019
12
0.170
Why?
Cost of Illness
1
2020
70
0.170
Why?
Hospitals, University
1
2019
31
0.170
Why?
Randomized Controlled Trials as Topic
3
2013
510
0.170
Why?
Peritoneal Lavage
1
2019
1
0.170
Why?
Splenectomy
3
2017
21
0.170
Why?
Leukocytes, Mononuclear
1
2019
56
0.170
Why?
Quality of Health Care
1
2020
147
0.170
Why?
Leadership
1
2019
37
0.170
Why?
Tissue Array Analysis
1
2019
34
0.170
Why?
Immunohistochemistry
4
2008
538
0.170
Why?
Endoscopy, Digestive System
1
2019
10
0.160
Why?
Laparoscopy
2
2019
172
0.160
Why?
Seroma
1
2019
5
0.160
Why?
Self Efficacy
1
2019
78
0.160
Why?
Antineoplastic Agents, Hormonal
3
2015
42
0.160
Why?
Odds Ratio
7
2015
472
0.160
Why?
Lower Gastrointestinal Tract
1
2018
3
0.160
Why?
Surgical Wound Dehiscence
1
2019
13
0.160
Why?
Myeloid Cells
1
2019
39
0.160
Why?
Gastrointestinal Hemorrhage
1
2019
23
0.160
Why?
Membrane Proteins
1
2020
256
0.160
Why?
Vascular Neoplasms
2
2010
12
0.160
Why?
Digestive System Surgical Procedures
2
2011
20
0.160
Why?
Cell Proliferation
2
2018
604
0.160
Why?
Coronavirus Infections
1
2020
98
0.160
Why?
Pneumonia, Viral
1
2020
102
0.160
Why?
Intestinal Neoplasms
1
2018
1
0.160
Why?
Vena Cava, Inferior
2
2010
30
0.150
Why?
Urachus
1
2017
3
0.150
Why?
Intensive Care Units
2
2015
110
0.150
Why?
Appendectomy
1
2018
16
0.150
Why?
Practice Guidelines as Topic
2
2013
407
0.150
Why?
Anesthesia, Conduction
1
2018
25
0.150
Why?
Skin Diseases
1
2019
142
0.150
Why?
Diaphragm
2
2014
39
0.150
Why?
Dermatology
1
2019
163
0.150
Why?
Hospital Charges
1
2017
15
0.150
Why?
Risk Assessment
7
2017
1426
0.140
Why?
Neoplastic Cells, Circulating
1
2017
23
0.140
Why?
Crohn Disease
1
2017
26
0.140
Why?
Medicaid
2
2008
94
0.140
Why?
Animals
5
2019
7541
0.140
Why?
Intestinal Perforation
1
2016
9
0.140
Why?
Cross Infection
1
2017
55
0.140
Why?
Decision Support Techniques
1
2018
128
0.140
Why?
Lymphedema
2
2017
4
0.140
Why?
Vomiting
2
2014
24
0.140
Why?
Emotions
1
2016
58
0.140
Why?
Nausea
2
2014
53
0.130
Why?
Mitotane
1
2015
2
0.130
Why?
Taxoids
2
2013
59
0.130
Why?
Gastric Stump
1
2015
2
0.130
Why?
Linitis Plastica
1
2015
2
0.130
Why?
Gastroenterostomy
1
2015
2
0.130
Why?
Anastomosis, Roux-en-Y
1
2015
6
0.130
Why?
African Americans
3
2017
1425
0.130
Why?
Biliary Tract Surgical Procedures
1
2015
7
0.130
Why?
Peritoneal Stomata
1
2015
3
0.130
Why?
Bile Ducts
1
2015
20
0.130
Why?
Bile Duct Neoplasms
1
2015
32
0.130
Why?
Tumor Cells, Cultured
4
2018
170
0.130
Why?
Forecasting
1
2016
143
0.130
Why?
Genetic Predisposition to Disease
3
2014
835
0.130
Why?
Patient Admission
1
2015
60
0.130
Why?
Blood Vessels
1
2015
48
0.130
Why?
Anemia
1
2015
58
0.120
Why?
Pain Measurement
1
2016
350
0.120
Why?
Carcinoma, Signet Ring Cell
1
2014
6
0.120
Why?
Skilled Nursing Facilities
1
2014
11
0.120
Why?
Anastomosis, Surgical
2
2015
58
0.120
Why?
Drug Therapy, Combination
2
2013
288
0.120
Why?
Gastrointestinal Stromal Tumors
1
2014
12
0.120
Why?
Protein-Tyrosine Kinases
1
2014
40
0.120
Why?
Abdominal Cavity
1
2014
5
0.120
Why?
Gastrostomy
1
2014
17
0.120
Why?
Myocardial Infarction
1
2019
475
0.120
Why?
Thromboembolism
1
2014
34
0.120
Why?
Appendix
1
2014
4
0.120
Why?
Gastrointestinal Neoplasms
1
2014
31
0.120
Why?
Nervous System Diseases
1
2014
39
0.120
Why?
Neoplasm, Residual
3
2016
25
0.120
Why?
Thiosulfates
1
2013
3
0.120
Why?
Axilla
3
2020
18
0.110
Why?
Granulocyte Colony-Stimulating Factor
1
2013
24
0.110
Why?
Ascites
1
2013
16
0.110
Why?
Urinary Tract
1
2013
22
0.110
Why?
Urologic Diseases
1
2013
27
0.110
Why?
Reconstructive Surgical Procedures
1
2015
198
0.110
Why?
Patient Discharge
1
2014
188
0.110
Why?
Comparative Effectiveness Research
1
2013
25
0.110
Why?
BRCA2 Protein
1
2013
3
0.110
Why?
Tumor Burden
3
2017
58
0.110
Why?
BRCA1 Protein
1
2013
10
0.110
Why?
Genotype
2
2012
733
0.110
Why?
Fatty Acids
1
2013
98
0.100
Why?
Cross-Sectional Studies
2
2019
1531
0.100
Why?
Genomics
1
2013
85
0.100
Why?
Maximum Tolerated Dose
2
2012
62
0.100
Why?
Anthracyclines
1
2013
62
0.100
Why?
Tissue Expansion Devices
1
2011
10
0.100
Why?
Immunotherapy, Active
1
2011
6
0.100
Why?
Body Mass Index
3
2016
923
0.100
Why?
Clinical Trials, Phase III as Topic
1
2011
30
0.100
Why?
Polymorphism, Single Nucleotide
3
2014
1062
0.100
Why?
Diet
1
2014
391
0.100
Why?
Genes, BRCA1
1
2011
9
0.100
Why?
Evidence-Based Medicine
1
2013
217
0.100
Why?
Immunoenzyme Techniques
3
2015
52
0.100
Why?
Chi-Square Distribution
3
2009
297
0.100
Why?
Heterozygote
1
2011
59
0.100
Why?
Oligonucleotide Array Sequence Analysis
1
2012
160
0.100
Why?
Clinical Competence
1
2014
333
0.100
Why?
Sleep
1
2012
92
0.100
Why?
Case-Control Studies
5
2014
898
0.100
Why?
Diabetes Mellitus
1
2014
411
0.100
Why?
Magnetic Resonance Imaging
2
2018
1328
0.090
Why?
Nucleic Acid Amplification Techniques
1
2011
10
0.090
Why?
Pancreatitis
1
2011
22
0.090
Why?
Organizational Objectives
1
2010
23
0.090
Why?
Poverty
2
2008
111
0.090
Why?
Cooperative Behavior
1
2010
81
0.090
Why?
Phenotype
1
2012
632
0.090
Why?
Patient Satisfaction
1
2011
240
0.090
Why?
Research Design
1
2012
313
0.090
Why?
Smoking
2
2017
497
0.090
Why?
Cost-Benefit Analysis
1
2010
185
0.090
Why?
Tomography, X-Ray Computed
3
2018
918
0.080
Why?
Fluorouracil
4
2012
81
0.080
Why?
Equipment Design
2
2007
171
0.080
Why?
Medical Records
4
2012
76
0.080
Why?
Immunotherapy
2
2019
81
0.080
Why?
Protein Biosynthesis
1
2009
40
0.080
Why?
Hysterectomy
1
2009
46
0.080
Why?
Multifactorial Inheritance
1
2008
21
0.080
Why?
Glutathione S-Transferase pi
1
2008
2
0.080
Why?
Aryl Hydrocarbon Hydroxylases
1
2008
4
0.080
Why?
Glutathione Transferase
1
2008
13
0.080
Why?
Telomere
1
2008
10
0.080
Why?
Models, Genetic
1
2008
94
0.080
Why?
Comorbidity
3
2017
566
0.080
Why?
Radiation Tolerance
1
2008
24
0.080
Why?
Ascitic Fluid
1
2007
10
0.080
Why?
Perfusion
2
2020
73
0.070
Why?
Leg
1
2007
65
0.070
Why?
Paclitaxel
3
2013
67
0.070
Why?
Neck
1
2007
27
0.070
Why?
Radiation Injuries
1
2008
76
0.070
Why?
NAD
1
2007
27
0.070
Why?
Hematologic Diseases
1
2007
23
0.070
Why?
Neoplasm Proteins
3
2017
148
0.070
Why?
Cell Death
1
2007
77
0.070
Why?
Health Surveys
1
2007
196
0.070
Why?
Sequence Analysis, DNA
2
2017
137
0.070
Why?
Neutropenia
2
2008
29
0.070
Why?
Carcinoembryonic Antigen
1
2006
7
0.070
Why?
Patient Participation
1
2007
82
0.070
Why?
False Negative Reactions
1
2006
20
0.070
Why?
Health Promotion
1
2009
246
0.070
Why?
Keratins
1
2006
39
0.070
Why?
Rupture
1
2006
34
0.070
Why?
Dose-Response Relationship, Drug
2
2012
633
0.070
Why?
Fluorescent Dyes
1
2006
48
0.070
Why?
Telomerase
1
2006
22
0.070
Why?
Exercise
1
2011
672
0.070
Why?
Survival
1
2006
13
0.070
Why?
Continental Population Groups
1
2007
237
0.070
Why?
Endosonography
1
2006
56
0.070
Why?
Suture Techniques
1
2006
61
0.060
Why?
International Agencies
2
2017
10
0.060
Why?
Hemangioma, Cavernous
1
2004
3
0.060
Why?
Drug Administration Schedule
3
2012
276
0.060
Why?
Nevus
1
2004
15
0.060
Why?
Malignant Carcinoid Syndrome
1
2003
1
0.060
Why?
Gene Amplification
1
2003
8
0.060
Why?
Anoikis
1
2003
2
0.060
Why?
Tropomyosin
1
2003
3
0.060
Why?
In Situ Hybridization, Fluorescence
1
2003
40
0.060
Why?
Monitoring, Intraoperative
1
2004
42
0.060
Why?
Carcinoma, Neuroendocrine
1
2003
12
0.060
Why?
Hypercalcemia
1
2003
10
0.060
Why?
Hyperplasia
1
2003
41
0.060
Why?
Regression Analysis
1
2004
293
0.060
Why?
Massage
1
2003
12
0.060
Why?
Preoperative Period
2
2014
35
0.060
Why?
Flow Cytometry
1
2003
185
0.050
Why?
Drosophila Proteins
1
2003
45
0.050
Why?
Cell Biology
1
2002
2
0.050
Why?
Specimen Handling
1
2002
33
0.050
Why?
Recombinant Proteins
1
2003
247
0.050
Why?
Cryopreservation
1
2002
57
0.050
Why?
Polymerase Chain Reaction
3
2008
198
0.050
Why?
Image Processing, Computer-Assisted
1
2003
226
0.050
Why?
DNA Mutational Analysis
1
2020
72
0.050
Why?
Personnel, Hospital
1
2020
13
0.040
Why?
Infection Control
1
2020
28
0.040
Why?
Appointments and Schedules
1
2019
22
0.040
Why?
Ohio
1
2019
58
0.040
Why?
Vulnerable Populations
1
2019
34
0.040
Why?
Propensity Score
1
2019
39
0.040
Why?
Tissue Fixation
1
2019
10
0.040
Why?
Health Plan Implementation
1
2019
22
0.040
Why?
Paraffin Embedding
1
2019
10
0.040
Why?
Remission Induction
2
2010
84
0.040
Why?
Formaldehyde
1
2019
11
0.040
Why?
Triage
1
2020
72
0.040
Why?
Surgical Procedures, Operative
1
2020
84
0.040
Why?
Pancreatic Diseases
1
2019
18
0.040
Why?
Program Evaluation
1
2019
185
0.040
Why?
Hospital Costs
1
2019
38
0.040
Why?
Single-Blind Method
2
2011
203
0.040
Why?
Reference Values
1
2018
246
0.040
Why?
Socioeconomic Factors
1
2019
423
0.040
Why?
Intestine, Small
1
2018
40
0.040
Why?
Cell Survival
1
2018
284
0.040
Why?
ROC Curve
1
2018
164
0.040
Why?
Pathology, Molecular
1
2017
16
0.040
Why?
Intention to Treat Analysis
1
2017
28
0.040
Why?
Genes, erbB-1
1
2017
15
0.040
Why?
Clone Cells
1
2017
36
0.040
Why?
Genes, Neoplasm
1
2017
18
0.040
Why?
Healthcare Disparities
1
2019
167
0.040
Why?
Genes, ras
1
2017
26
0.040
Why?
DNA-Binding Proteins
2
2011
147
0.040
Why?
Tumor Suppressor Protein p53
1
2017
82
0.040
Why?
Protein Kinase Inhibitors
1
2017
85
0.040
Why?
Diarrhea
2
2008
60
0.030
Why?
Neoplastic Stem Cells
1
2017
99
0.030
Why?
Heart Diseases
1
2017
116
0.030
Why?
Pancreatic Fistula
1
2016
3
0.030
Why?
Postoperative Period
1
2016
97
0.030
Why?
Abdomen
1
2016
43
0.030
Why?
Chemoprevention
1
2015
11
0.030
Why?
Neoplasms, Second Primary
1
2015
16
0.030
Why?
Platelet Count
1
2015
23
0.030
Why?
Hydrocortisone
1
2015
57
0.030
Why?
Lymphocyte Count
1
2015
24
0.030
Why?
Hospitalization
1
2019
470
0.030
Why?
Stomach
1
2015
15
0.030
Why?
Shock, Septic
1
2015
25
0.030
Why?
Lung Diseases
1
2015
46
0.030
Why?
Signal Transduction
1
2019
682
0.030
Why?
Blood Loss, Surgical
1
2015
49
0.030
Why?
Colon
1
2015
51
0.030
Why?
Cause of Death
1
2015
236
0.030
Why?
Spleen
1
2015
87
0.030
Why?
Pancreas
1
2015
103
0.030
Why?
Analysis of Variance
1
2015
463
0.030
Why?
beta Carotene
1
2014
6
0.030
Why?
Folic Acid Deficiency
1
2014
2
0.030
Why?
Ultrasonography
1
2017
379
0.030
Why?
Chemoembolization, Therapeutic
1
2014
9
0.030
Why?
Folic Acid
1
2014
12
0.030
Why?
Malnutrition
1
2014
17
0.030
Why?
Serum Albumin
1
2014
54
0.030
Why?
Omentum
1
2014
24
0.030
Why?
Micronutrients
1
2014
18
0.030
Why?
Pneumonia
1
2014
68
0.030
Why?
Thrombosis
1
2014
73
0.030
Why?
Zinc
1
2014
32
0.030
Why?
Respiratory Insufficiency
1
2014
57
0.030
Why?
Receptors, Estrogen
1
2014
113
0.030
Why?
Prevalence
1
2017
981
0.030
Why?
Arrhythmias, Cardiac
1
2014
89
0.030
Why?
Energy Intake
1
2014
128
0.030
Why?
Ovariectomy
1
2014
166
0.030
Why?
Cyclophosphamide
1
2013
38
0.030
Why?
American Recovery and Reinvestment Act
1
2013
1
0.030
Why?
Mice
1
2019
2484
0.030
Why?
Societies, Scientific
1
2013
15
0.030
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2013
4
0.030
Why?
Research Support as Topic
1
2013
26
0.030
Why?
National Cancer Institute (U.S.)
1
2013
19
0.030
Why?
Doxorubicin
1
2013
82
0.030
Why?
Carcinoma, Non-Small-Cell Lung
1
2013
101
0.030
Why?
Liver
1
2015
484
0.030
Why?
Surgery, Plastic
1
2012
27
0.030
Why?
Physician's Role
1
2012
40
0.020
Why?
Europe
1
2012
82
0.020
Why?
Multicenter Studies as Topic
1
2012
105
0.020
Why?
Physical Therapy Modalities
1
2011
64
0.020
Why?
Nuclear Proteins
1
2011
75
0.020
Why?
Cell Cycle Proteins
1
2011
55
0.020
Why?
Platinum Compounds
1
2010
3
0.020
Why?
Cell Line, Tumor
1
2013
726
0.020
Why?
Contrast Media
1
2010
138
0.020
Why?
Patient Compliance
1
2011
225
0.020
Why?
Temperature
1
2010
55
0.020
Why?
Sex Factors
1
2011
663
0.020
Why?
Patient Education as Topic
1
2011
271
0.020
Why?
Colonic Polyps
1
2008
15
0.020
Why?
Polymorphism, Single-Stranded Conformational
1
2008
6
0.020
Why?
Infusions, Intravenous
1
2008
100
0.020
Why?
Dose-Response Relationship, Radiation
1
2008
81
0.020
Why?
DNA Primers
1
2008
91
0.020
Why?
Patient Care
1
2008
30
0.020
Why?
Radiation Dosage
1
2008
84
0.020
Why?
Probability
1
2008
158
0.020
Why?
Confidence Intervals
1
2008
149
0.020
Why?
Administration, Oral
1
2008
187
0.020
Why?
Alleles
1
2008
248
0.020
Why?
SEER Program
1
2007
30
0.020
Why?
National Institutes of Health (U.S.)
1
2007
27
0.020
Why?
Gender Identity
1
2007
23
0.020
Why?
Base Sequence
1
2008
252
0.020
Why?
Leucovorin
1
2007
24
0.020
Why?
Drainage
1
2007
72
0.020
Why?
Sex Distribution
1
2007
191
0.020
Why?
Age Distribution
1
2007
206
0.020
Why?
Observer Variation
1
2006
105
0.020
Why?
Vacuum
1
2006
22
0.020
Why?
Thrombocytopenia
1
2005
30
0.020
Why?
Gastrointestinal Diseases
1
2005
43
0.020
Why?
Fatigue
1
2005
85
0.020
Why?
Blood Vessel Prosthesis Implantation
1
2005
69
0.020
Why?
Wound Healing
1
2006
185
0.010
Why?
S100 Proteins
1
2004
18
0.010
Why?
Polymorphism, Restriction Fragment Length
1
2003
10
0.010
Why?
Antigens, Neoplasm
1
2004
45
0.010
Why?
Protein Isoforms
1
2003
57
0.010
Why?
Genes, Tumor Suppressor
1
2003
34
0.010
Why?
Stereotaxic Techniques
1
2003
23
0.010
Why?
Cell Transformation, Neoplastic
1
2003
57
0.010
Why?
Tumor Suppressor Proteins
1
2003
71
0.010
Why?
Patient Care Planning
1
2004
58
0.010
Why?
Down-Regulation
1
2003
142
0.010
Why?
Postoperative Care
1
2003
76
0.010
Why?
Tamoxifen
1
2002
59
0.010
Why?
RNA, Messenger
1
2003
508
0.010
Why?
Gene Expression Regulation
1
2003
495
0.010
Why?
Levine's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (567)
Explore
_
Co-Authors (59)
Explore
_
Similar People (49)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_